{"url":"https://lda.senate.gov/api/v1/filings/7c7a6336-8072-4ecc-bcdf-df3af1f46fdf/","filing_uuid":"7c7a6336-8072-4ecc-bcdf-df3af1f46fdf","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2025,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/7c7a6336-8072-4ecc-bcdf-df3af1f46fdf/print/","filing_document_content_type":"text/html","income":null,"expenses":"150000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Joyce Gresko, Washington Counsel","dt_posted":"2026-01-20T12:35:41-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2500 MetroHealth Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Cleveland","registrant_state":"OH","registrant_zip":"44109","registrant":{"id":288236,"url":"https://lda.senate.gov/api/v1/registrants/288236/","house_registrant_id":37072,"name":"THE METROHEALTH SYSTEM","description":"healthcare","address_1":"2500 MetroHealth Drive","address_2":null,"address_3":null,"address_4":null,"city":"Cleveland","state":"OH","state_display":"Ohio","zip":"44109","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALLISON POULIOS","contact_telephone":"+1 216-339-6806","dt_updated":"2026-07-28T17:45:17.888385-04:00"},"client":{"id":177076,"url":"https://lda.senate.gov/api/v1/clients/177076/","client_id":12,"name":"THE METROHEALTH SYSTEM","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"OH","state_display":"Ohio","country":"US","country_display":"United States of America","ppb_state":"OH","ppb_state_display":"Ohio","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-01-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicaid State Directed Payments; 340B Modernization; Funding for Disproportionate Share Hospitals (Medicaid DSH); Funding for Medicare graduate medical education (GME); Medicare site neutrality policies; support of telehealth policies; H.R. 7053/S. 3792 - acute hospital care at home waiver flexibility; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R.3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 5378, the Lower Costs, More Transparency Act; H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 7327, the Protecting Front Line Multimission Hospitals Act of 2024; S. 3450, the Mental and Physical Health Care Comorbidities Act of 2023; and H.R. 10337, Expanding the Health Care Workforce Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73043,"prefix":null,"prefix_display":null,"first_name":"ALLISON","nickname":null,"middle_name":null,"last_name":"POULIOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146133,"prefix":null,"prefix_display":null,"first_name":"KINSEY","nickname":null,"middle_name":null,"last_name":"JOLLIFF","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Sustainability of safety net health systems; social determinants of health; promoting coordinated care; support of telehealth policies; 340B Protect Act, H.R. 4390; H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program; H.R. 3281, the Transparent PRICE Act; H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023; H.R. 2665, the Supporting Safety Net Hospitals Act; and H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023; H.R. 5378, the Lower Costs, More Transparency Act; S.3548, the Health Care Prices Revealed and Information to Consumers Explained Transparency Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act; H.R. 10337, Expanding the Health Care Workforce Act; and H.R. 4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73043,"prefix":null,"prefix_display":null,"first_name":"ALLISON","nickname":null,"middle_name":null,"last_name":"POULIOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146133,"prefix":null,"prefix_display":null,"first_name":"KINSEY","nickname":null,"middle_name":null,"last_name":"JOLLIFF","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 5860, the Continuing Appropriations Act, 2024 and Other Extensions Act; H.R.6363, the Further Continuing Appropriations and Other Extensions Act, 2024; H.R. 2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024; H.R. 7463, Extension of Continuing Appropriations and Other Matters Act, 2024; H.R. 10545, the American Relief Act, 2025; H.R.1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 1, the One Big Beautiful Bill Act; and H.R. 5371, the Continuing Appropriations and Extensions Act, 2026.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":146133,"prefix":null,"prefix_display":null,"first_name":"KINSEY","nickname":null,"middle_name":null,"last_name":"JOLLIFF","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73043,"prefix":null,"prefix_display":null,"first_name":"ALLISON","nickname":null,"middle_name":null,"last_name":"POULIOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"H.R. 8574, the 340B Affording Care for Communities and Ensuring a Strong Safety-net Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73043,"prefix":null,"prefix_display":null,"first_name":"ALLISON","nickname":null,"middle_name":null,"last_name":"POULIOS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146133,"prefix":null,"prefix_display":null,"first_name":"KINSEY","nickname":null,"middle_name":null,"last_name":"JOLLIFF","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}